12 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Propionibacterium acnes ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... #management #treatment ... #pharmacology #
Oral Antibiotics for Acne - Indicated for Moderate-to-Severe Acne 
First-Line Drug Class: Tetracyclines 

In the last
Oral Antibiotics ... the last post I reviewed ... mild acne treatment ... #Acne #Oral #Antibiotics ... #Pharmacology #
This is a quick overview of hormonal acne treatment for the medical student and resident.

Keep in
treatment for the ... #dermatology #treatment ... #photo #management ... vulgaris: a review ... comparing efficacy of antibiotics
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
With Excellent Oral ... #Antibiotics #Osteomyelitis ... #management #treatment ... #pharmacology # ... idsa
Tetracyclines – Doxycycline, Tetracycline, Minocycline - Antibiotics Class Overview

- 30S Inhibitors (PO and IV)
Spectrum: Fairly broad
Minocycline - Antibiotics ... Inhibitors (PO and IV ... malaria prophylaxis, acne ... #Pharmacology #Antibiotics ... #Review #Overview
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Tuberculosis #MDRTB #management ... #regimens #pharmacology ... #dosing #idsa #
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Anti-Pseudomonal - Antibiotics ... empiric Pseudomonas treatment ... and Polymyxin B(IV ... ) #Pharmacology ... #Antibiotics #Review
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... acyclovir 5 mg/kg IV ... regress, change to oral ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... • Aggressive oral ... and/or IV rehydration ... Cryptosporidiosis #IDSA ... infections #HIVAIDS #pharmacology